A feasibility study of a theory-based intervention to improve appropriate polypharmacy for older people in primary care

被引:14
作者
Cadogan C.A. [1 ]
Ryan C. [1 ]
Gormley G.J. [2 ]
Francis J.J. [3 ]
Passmore P. [4 ]
Kerse N. [5 ]
Hughes C.M. [6 ]
机构
[1] Royal College of Surgeons in Ireland, School of Pharmacy, Dublin
[2] Queen's University Belfast, Department of General Practice, Belfast
[3] City University of London, School of Health Sciences, London
[4] Queen's University Belfast, Centre for Public Health, Belfast
[5] University of Auckland, School of Population Health, Auckland
[6] Queen's University Belfast, School of Pharmacy, 97 Lisburn Road, Belfast
关键词
Behaviour change; Feasibility; General practice; Intervention; Polypharmacy; Prescribing; Theoretical Domains Framework;
D O I
10.1186/s40814-017-0166-3
中图分类号
学科分类号
摘要
Background: A general practitioner (GP)-targeted intervention aimed at improving the prescribing of appropriate polypharmacy for older people was previously developed using a systematic, theory-based approach based on the UK Medical Research Council's complex intervention framework. The primary intervention component comprised a video demonstration of a GP prescribing appropriate polypharmacy during a consultation with an older patient. The video was delivered to GPs online and included feedback emphasising the positive outcomes of performing the behaviour. As a complementary intervention component, patients were invited to scheduled medication review consultations with GPs. This study aimed to test the feasibility of the intervention and study procedures (recruitment, data collection). Methods: GPs from two general practices were given access to the video, and reception staff scheduled consultations with older patients receiving polypharmacy (≥4 medicines). Primary feasibility study outcomes were the usability and acceptability of the intervention to GPs. Feedback was collected from GP and patient participants using structured questionnaires. Clinical data were also extracted from recruited patients' medical records (baseline and 1 month post-consultation). The feasibility of applying validated assessment of prescribing appropriateness (STOPP/START criteria, Medication Appropriateness Index) and medication regimen complexity (Medication Regimen Complexity Index) to these data was investigated. Data analysis was descriptive, providing an overview of participants' feedback and clinical assessment findings. Results: Four GPs and ten patients were recruited across two practices. The intervention was considered usable and acceptable by GPs. Some reservations were expressed by GPs as to whether the video truly reflected resource and time pressures encountered in the general practice working environment. Patient feedback on the scheduled consultations was positive. Patients welcomed the opportunity to have their medications reviewed. Due to the short time to follow-up and a lack of detailed clinical information in patient records, it was not feasible to detect any prescribing changes or to apply the assessment tools to patients' clinical data. Conclusion: The findings will help to further refine the intervention and study procedures (including time to follow-up) which will be tested in a randomised pilot study that will inform the design of a definitive trial to evaluate the intervention's effectiveness. © 2017 The Author(s).
引用
收藏
相关论文
共 37 条
[1]  
Avorn J., Medication use in older patients: better policy could encourage better practice, JAMA, 304, 14, pp. 1606-1607, (2010)
[2]  
Sumukadas D., McMurdo M.E., Mangoni A.A., Guthrie B., Temporal trends in anticholinergic medication prescription in older people: repeated cross-sectional analysis of population prescribing data, Age Ageing, 43, 4, pp. 515-521, (2014)
[3]  
Hovstadius B., Hovstadius K., Astrand B., Petersson G., Increasing polypharmacy-an individual-based study of the Swedish population 2005-2008, BMC Clin. Pharmacol., 10, (2010)
[4]  
Payne R.A., Avery A.J., Polypharmacy: one of the greatest prescribing challenges in general practice, Br. J. Gen. Pract., 61, 583, pp. 83-84, (2011)
[5]  
Polypharmacy and medicines optimisation: making it safe and sound, (2013)
[6]  
Cahir C., Fahey T., Teeling M., Teljeur C., Feely J., Bennett K., Potentially inappropriate prescribing and cost outcomes for older people: a national population study, Br. J. Clin. Pharmacol., 69, 5, pp. 543-552, (2010)
[7]  
Bradley M.C., Fahey T., Cahir C., Bennett K., O'Reilly D., Parsons C., Hughes C.M., Potentially inappropriate prescribing and cost outcomes for older people: a cross-sectional study using the Northern Ireland Enhanced Prescribing Database, Eur. J. Clin. Pharmacol., 68, 10, pp. 1425-1433, (2012)
[8]  
Maher R.L., Hanlon J., Hajjar E.R., Clinical consequences of polypharmacy in elderly, Expert Opin. Drug Saf, 13, 1, pp. 57-65, (2014)
[9]  
Barnett K., Mercer S.W., Norbury M., Watt G., Wyke S., Guthrie B., Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study, Lancet, 380, 9836, pp. 37-43, (2012)
[10]  
Hughes L.D., McMurdo M.E., Guthrie B., Guidelines for people not for diseases: the challenges of applying UK clinical guidelines to people with multimorbidity, Age Ageing, 42, 1, pp. 62-69, (2013)